Global and China Neurological Disorder Drugs Market Insights, Forecast to 2027

Global and China Neurological Disorder Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Neurological Disorder Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Disorder Drugs Market Size Growth Rate by Type
1.2.2 Antipsychotic
1.2.3 Hypnotic & Sedative
1.2.4 Analgesics
1.2.5 Anticoagulants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Disorder Drugs Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurological Disorder Drugs Market Size, Estimates and Forecasts
2.1.1 Global Neurological Disorder Drugs Revenue 2016-2027
2.1.2 Global Neurological Disorder Drugs Sales 2016-2027
2.2 Global Neurological Disorder Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Neurological Disorder Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Neurological Disorder Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Neurological Disorder Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Neurological Disorder Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Neurological Disorder Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Neurological Disorder Drugs Revenue Forecast by Region (2022-2027)
3 Global Neurological Disorder Drugs Competitor Landscape by Players
3.1 Global Top Neurological Disorder Drugs Manufacturers by Sales
3.1.1 Global Neurological Disorder Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Neurological Disorder Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Neurological Disorder Drugs Manufacturers by Revenue
3.2.1 Key Neurological Disorder Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Neurological Disorder Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Neurological Disorder Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Neurological Disorder Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Neurological Disorder Drugs Revenue in 2020
3.2.6 Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Neurological Disorder Drugs Price by Manufacturers
3.4 Global Neurological Disorder Drugs Manufacturing Base Distribution, Product Types
3.4.1 Neurological Disorder Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neurological Disorder Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Neurological Disorder Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Neurological Disorder Drugs Market Size by Type (2016-2021)
4.1.1 Global Neurological Disorder Drugs Sales by Type (2016-2021)
4.1.2 Global Neurological Disorder Drugs Revenue by Type (2016-2021)
4.1.3 Neurological Disorder Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Neurological Disorder Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Neurological Disorder Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Neurological Disorder Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Neurological Disorder Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Neurological Disorder Drugs Market Size by Application (2016-2021)
5.1.1 Global Neurological Disorder Drugs Sales by Application (2016-2021)
5.1.2 Global Neurological Disorder Drugs Revenue by Application (2016-2021)
5.1.3 Neurological Disorder Drugs Price by Application (2016-2021)
5.2 Neurological Disorder Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Neurological Disorder Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Neurological Disorder Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Neurological Disorder Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Neurological Disorder Drugs Market Size YoY Growth 2016-2027
6.1.1 China Neurological Disorder Drugs Sales YoY Growth 2016-2027
6.1.2 China Neurological Disorder Drugs Revenue YoY Growth 2016-2027
6.1.3 China Neurological Disorder Drugs Market Share in Global Market 2016-2027
6.2 China Neurological Disorder Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Neurological Disorder Drugs Players by Sales (2016-2021)
6.2.2 China Top Neurological Disorder Drugs Players by Revenue (2016-2021)
6.3 China Neurological Disorder Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Neurological Disorder Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Neurological Disorder Drugs Price by Type (2016-2021)
6.4 China Neurological Disorder Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Neurological Disorder Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Neurological Disorder Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Neurological Disorder Drugs Price Forecast by Type (2022-2027)
6.5 China Neurological Disorder Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Neurological Disorder Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Neurological Disorder Drugs Price by Application (2016-2021)
6.6 China Neurological Disorder Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Neurological Disorder Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Neurological Disorder Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Neurological Disorder Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Neurological Disorder Drugs Market Size YoY Growth 2016-2027
7.2 North America Neurological Disorder Drugs Market Facts & Figures by Country
7.2.1 North America Neurological Disorder Drugs Sales by Country (2016-2021)
7.2.2 North America Neurological Disorder Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Neurological Disorder Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Neurological Disorder Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Neurological Disorder Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Neurological Disorder Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Neurological Disorder Drugs Market Size YoY Growth 2016-2027
9.2 Europe Neurological Disorder Drugs Market Facts & Figures by Country
9.2.1 Europe Neurological Disorder Drugs Sales by Country (2016-2021)
9.2.2 Europe Neurological Disorder Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Neurological Disorder Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Neurological Disorder Drugs Market Facts & Figures by Country
10.2.1 Latin America Neurological Disorder Drugs Sales by Country (2016-2021)
10.2.2 Latin America Neurological Disorder Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Neurological Disorder Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Neurological Disorder Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Neurological Disorder Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Neurological Disorder Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Neurological Disorder Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Neurological Disorder Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Merck & Co.
12.3.1 Merck & Co. Corporation Information
12.3.2 Merck & Co. Description and Business Overview
12.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck & Co. Neurological Disorder Drugs Products Offered
12.3.5 Merck & Co. Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Description and Business Overview
12.4.3 Bayer Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Neurological Disorder Drugs Products Offered
12.4.5 Bayer Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Description and Business Overview
12.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca Neurological Disorder Drugs Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Corporation Information
12.6.2 Boehringer Ingelheim Description and Business Overview
12.6.3 Boehringer Ingelheim Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Boehringer Ingelheim Neurological Disorder Drugs Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Corporation Information
12.7.2 Teva Pharmaceutical Description and Business Overview
12.7.3 Teva Pharmaceutical Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical Neurological Disorder Drugs Products Offered
12.7.5 Teva Pharmaceutical Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Neurological Disorder Drugs Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Neurological Disorder Drugs Industry Trends
13.2 Neurological Disorder Drugs Market Drivers
13.3 Neurological Disorder Drugs Market Challenges
13.4 Neurological Disorder Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neurological Disorder Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Neurological Disorder Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Antipsychotic
Table 3. Major Manufacturers of Hypnotic & Sedative
Table 4. Major Manufacturers of Analgesics
Table 5. Major Manufacturers of Anticoagulants
Table 6. Major Manufacturers of Others
Table 7. Global Neurological Disorder Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 8. Global Neurological Disorder Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Neurological Disorder Drugs Sales by Regions (2016-2021) & (K Units)
Table 10. Global Neurological Disorder Drugs Sales Market Share by Regions (2016-2021)
Table 11. Global Neurological Disorder Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Neurological Disorder Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 13. Global Neurological Disorder Drugs Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Neurological Disorder Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Neurological Disorder Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Neurological Disorder Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 17. Global Neurological Disorder Drugs Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Neurological Disorder Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 19. Neurological Disorder Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Neurological Disorder Drugs Revenue Share by Manufacturers (2016-2021)
Table 21. Global Neurological Disorder Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Neurological Disorder Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Disorder Drugs as of 2020)
Table 23. Key Manufacturers Neurological Disorder Drugs Price (2016-2021) (USD/Unit)
Table 24. Neurological Disorder Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Neurological Disorder Drugs Product Type
Table 26. Date of International Manufacturers Enter into Neurological Disorder Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Neurological Disorder Drugs Sales by Type (2016-2021) (K Units)
Table 29. Global Neurological Disorder Drugs Sales Share by Type (2016-2021)
Table 30. Global Neurological Disorder Drugs Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Neurological Disorder Drugs Revenue Share by Type (2016-2021)
Table 32. Neurological Disorder Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 33. Global Neurological Disorder Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 34. Global Neurological Disorder Drugs Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Neurological Disorder Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Neurological Disorder Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Neurological Disorder Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 38. Global Neurological Disorder Drugs Sales by Application (2016-2021) (K Units)
Table 39. Global Neurological Disorder Drugs Sales Share by Application (2016-2021)
Table 40. Global Neurological Disorder Drugs Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Neurological Disorder Drugs Revenue Share by Application (2016-2021)
Table 42. Neurological Disorder Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 43. Global Neurological Disorder Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 44. Global Neurological Disorder Drugs Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Neurological Disorder Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Neurological Disorder Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Neurological Disorder Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 48. China Neurological Disorder Drugs Sales (K Units) of Key Companies (2016-2021)
Table 49. China Neurological Disorder Drugs Sales Share by Company (2016-2021)
Table 50. China Neurological Disorder Drugs Revenue (US$ Million) by Company (2016-2021)
Table 51. China Neurological Disorder Drugs Revenue Share by Company (2016-2021)
Table 52. China Neurological Disorder Drugs Sales (K Units) by Type (2016-2021)
Table 53. China Neurological Disorder Drugs Sales Share by Type (2016-2021)
Table 54. China Neurological Disorder Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Neurological Disorder Drugs Price (USD/Unit) by Type (2016-2021)
Table 56. China Neurological Disorder Drugs Sales (K Units) by Type (2022-2027)
Table 57. China Neurological Disorder Drugs Sales Share by Type (2022-2027)
Table 58. China Neurological Disorder Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Neurological Disorder Drugs Revenue Share by Type (2022-2027)
Table 60. China Neurological Disorder Drugs Price (USD/Unit) by Type (2022-2027)
Table 61. China Neurological Disorder Drugs Sales (K Units) by Application (2016-2021)
Table 62. China Neurological Disorder Drugs Sales Share by Application (2016-2021)
Table 63. China Neurological Disorder Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Neurological Disorder Drugs Price (USD/Unit) by Application (2016-2021)
Table 65. China Neurological Disorder Drugs Sales (K Units) by Application (2022-2027)
Table 66. China Neurological Disorder Drugs Sales Share by Application (2022-2027)
Table 67. China Neurological Disorder Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Neurological Disorder Drugs Revenue Share by Application (2022-2027)
Table 69. China Neurological Disorder Drugs Price (USD/Unit) by Application (2022-2027)
Table 70. North America Neurological Disorder Drugs Sales by Country (2016-2021) & (K Units)
Table 71. North America Neurological Disorder Drugs Sales Market Share by Country (2016-2021)
Table 72. North America Neurological Disorder Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Neurological Disorder Drugs Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Neurological Disorder Drugs Sales by Region (2016-2021) & (K Units)
Table 75. Asia Pacific Neurological Disorder Drugs Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Neurological Disorder Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Neurological Disorder Drugs Revenue Market Share by Region (2016-2021)
Table 78. Europe Neurological Disorder Drugs Sales by Country (2016-2021) & (K Units)
Table 79. Europe Neurological Disorder Drugs Sales Market Share by Country (2016-2021)
Table 80. Europe Neurological Disorder Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Neurological Disorder Drugs Revenue Market Share by Country (2016-2021)
Table 82. Latin America Neurological Disorder Drugs Sales by Country (2016-2021) & (K Units)
Table 83. Latin America Neurological Disorder Drugs Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Neurological Disorder Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Neurological Disorder Drugs Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Neurological Disorder Drugs Sales by Country (2016-2021) & (K Units)
Table 87. Middle East and Africa Neurological Disorder Drugs Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Neurological Disorder Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Neurological Disorder Drugs Revenue Market Share by Country (2016-2021)
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Neurological Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 93. Novartis Neurological Disorder Drugs Product
Table 94. Novartis Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Neurological Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Merck & Co. Corporation Information
Table 101. Merck & Co. Description and Business Overview
Table 102. Merck & Co. Neurological Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 103. Merck & Co. Product
Table 104. Merck & Co. Recent Development
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Neurological Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. Bayer Product
Table 109. Bayer Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Neurological Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. AstraZeneca Product
Table 114. AstraZeneca Recent Development
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Neurological Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Boehringer Ingelheim Product
Table 119. Boehringer Ingelheim Recent Development
Table 120. Teva Pharmaceutical Corporation Information
Table 121. Teva Pharmaceutical Description and Business Overview
Table 122. Teva Pharmaceutical Neurological Disorder Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Teva Pharmaceutical Product
Table 124. Teva Pharmaceutical Recent Development
Table 125. Neurological Disorder Drugs Market Trends
Table 126. Neurological Disorder Drugs Market Drivers
Table 127. Neurological Disorder Drugs Market Challenges
Table 128. Neurological Disorder Drugs Market Restraints
Table 129. Neurological Disorder Drugs Customers List
Table 130. Neurological Disorder Drugs Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Disorder Drugs Product Picture
Figure 2. Global Neurological Disorder Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Antipsychotic Product Picture
Figure 4. Hypnotic & Sedative Product Picture
Figure 5. Analgesics Product Picture
Figure 6. Anticoagulants Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neurological Disorder Drugs Sales Market Share by Application in 2020 & 2027
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Neurological Disorder Drugs Report Years Considered
Figure 12. Global Neurological Disorder Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Neurological Disorder Drugs Market Size 2016-2027 (US$ Million)
Figure 14. Global Neurological Disorder Drugs Sales 2016-2027 (K Units)
Figure 15. Global Neurological Disorder Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Neurological Disorder Drugs Sales Market Share by Region (2016-2021)
Figure 17. Global Neurological Disorder Drugs Sales Market Share by Region in 2020
Figure 18. Global Neurological Disorder Drugs Revenue Market Share by Region (2016-2021)
Figure 19. Global Neurological Disorder Drugs Revenue Market Share by Region in 2020
Figure 20. Global Neurological Disorder Drugs Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Neurological Disorder Drugs Revenue in 2020
Figure 22. Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
Figure 24. Global Neurological Disorder Drugs Sales Market Share by Type in 2020
Figure 25. Global Neurological Disorder Drugs Revenue Market Share by Type (2016-2021)
Figure 26. Global Neurological Disorder Drugs Revenue Market Share by Type in 2020
Figure 27. Global Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
Figure 28. Global Neurological Disorder Drugs Sales Market Share by Application in 2020
Figure 29. Global Neurological Disorder Drugs Revenue Market Share by Application (2016-2021)
Figure 30. Global Neurological Disorder Drugs Revenue Market Share by Application in 2020
Figure 31. China Neurological Disorder Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 32. China Neurological Disorder Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Neurological Disorder Drugs Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Neurological Disorder Drugs Players Market Share by Revenue in Neurological Disorder Drugs in 2020
Figure 35. China Neurological Disorder Drugs Revenue Share by Type (2016-2021)
Figure 36. China Neurological Disorder Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Neurological Disorder Drugs Revenue Share by Application (2016-2021)
Figure 38. China Neurological Disorder Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Neurological Disorder Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Neurological Disorder Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Neurological Disorder Drugs Sales Market Share by Country in 2020
Figure 42. North America Neurological Disorder Drugs Revenue Market Share by Country in 2020
Figure 43. U.S. Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Neurological Disorder Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Neurological Disorder Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Neurological Disorder Drugs Sales Market Share by Country in 2020
Figure 50. Europe Neurological Disorder Drugs Revenue Market Share by Country in 2020
Figure 51. Germany Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Neurological Disorder Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Neurological Disorder Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Neurological Disorder Drugs Sales Market Share by Region in 2020
Figure 64. Asia Pacific Neurological Disorder Drugs Revenue Market Share by Region in 2020
Figure 65. China Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 72. India Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 74. Australia Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 76. Taiwan Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 78. Indonesia Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 80. Thailand Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 82. Malaysia Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 84. Philippines Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 86. Vietnam Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Neurological Disorder Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 88. Latin America Neurological Disorder Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Neurological Disorder Drugs Sales Market Share by Country in 2020
Figure 90. Latin America Neurological Disorder Drugs Revenue Market Share by Country in 2020
Figure 91. Mexico Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 92. Mexico Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 94. Brazil Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Neurological Disorder Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 96. Argentina Neurological Disorder Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Neurological Disorder Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 98. Middle East and Africa Neu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Loratadine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Loratadine market size was valued at US$ 138.8 million in 2023. With growing demand in downstream market, the Loratadine is forecast to a readjusted size of US$ 175.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Loratadine market. Loratadine are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Allergy Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Allergy Rhinitis Drugs market: According to our latest research, the global Allergy Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergy Rhinitis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overrea......

Global Loratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Loratadine market: According to our latest research, the global Loratadine market looks promising in the next 5 years. As of 2022, the global Loratadine market was estimated at USD 145.21 million, and it's anticipated to reach USD 210.61 million in 2028, with a CAGR of 6.39% during the forecast years. Loratadine is an antihistamine that reduces the effects of natural chemical histamine on the body. Histamine can produce symptoms of sneezing, itching,......

Global Desloratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Desloratadine market: According to our latest research, the global Desloratadine market looks promising in the next 5 years. As of 2022, the global Desloratadine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Desloratadine market, with a sys......

Global Clarityne Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Clarityne market: According to our latest research, the global Clarityne market looks promising in the next 5 years. As of 2022, the global Clarityne market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Clarityne market, with a systematical descri......

Global Allergic Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Allergic Rhinitis Drugs market: According to our latest research, the global Allergic Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergic Rhinitis Drugs market was estimated at USD 3956.8 million, and it's anticipated to reach USD 5997.75 million in 2028, with a CAGR of 7.18% during the forecast years. Allergic rhinitis, or hay fever, is an allergic reaction to specific allergens. An allergen is an innocuous sub......

Global Desloratadine Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 107

Belongs to the third generation histamine antagonist of tricyclic long - acting type. It is generally used to relieve the systemic and local symptoms of chronic idiopathic urticaria and perennial allergic rhinitis. The global Desloratadine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Desloratadine is estimated to increase from $ million......

Global Neurological Disorder Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 96

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson's Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing ris......

Global Allergic Rhinitis Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 125

In individuals with allergic rhinitis, the immune system overreacts and causes an allergic reaction when allergens such as pollen, mold, and dander come in contact with the immune system. The global Allergic Rhinitis Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The Americas accounted for the major shares of the allergy rhinitis drugs market during 2016. In ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs